Pediatric Spinal Hemangioblastomas: Clinical Features and Surgical Outcomes of 39 Cases
- PMID: 37016883
- PMCID: PMC10080452
- DOI: 10.14245/ns.2244970.485
Pediatric Spinal Hemangioblastomas: Clinical Features and Surgical Outcomes of 39 Cases
Abstract
Objective: Spinal hemangioblastomas (HBs) are a rare pathology, especially in the pediatric population. The natural history and long-term outcomes of pediatric patients with spinal HBs remain unclear due to their scarcity.
Methods: A retrospective review of the clinical data and treatment outcomes of children with spinal HBs in our institution from 2012 to 2021 was conducted.
Results: Thirty-nine pediatric patients were included, with an average age of 15.9 ± 2.9 years (range, 8-18 years), and 51.3% were female. Children were more likely to have von Hippel-Lindau (VHL) disease (p < 0.001), a family history of VHL (p < 0.001), multiple symptoms (p = 0.006), a shorter duration of symptoms (p < 0.001), and a larger lesion size (p = 0.004) and volume (p = 0.008) than their adult counterparts. The VHL-associated group of patients was more likely to present with multiple symptoms (p = 0.026), have a family history of VHL (p < 0.001), have multiple HBs (p < 0.001) and have synchronous intracranial lesions (p < 0.001) than the sporadic group. After surgery, 15 patients (38.5%) showed improved clinical outcomes, 17 patients (43.6%) remained unchanged, 4 patients (10.2%) worsened, and 3 patients (7.7%) died of tumor progression. During follow-up, there was a high rate of recurrence and repeated surgery, especially for children in the VHL-associated group.
Conclusion: Pediatric patients with spinal HBs appear to have a higher relapse risk than their adult counterparts. Therefore, life-long follow-up of these patients is necessary, especially for VHL-associated cases. Surgery can benefit children with HBs and should be considered early to avoid irreversible neurological deterioration.
Keywords: Hemangioblastoma; Natural history; Pediatrics; Spinal cord; von Hippel-Lindau disease.
Conflict of interest statement
The authors have nothing to disclose.
Figures
References
-
- Choyke PL, Glenn GM, Walther MM, et al. von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology. 1995;194:629–42. - PubMed
-
- Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet. 2003;361:2059–67. - PubMed
-
- Conway JE, Chou D, Clatterbuck RE, et al. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery. 2001;48:55–62. discussion 62-3. - PubMed
-
- Westwick HJ, Giguère JF, Shamji MF. Incidence and prognosis of spinal hemangioblastoma: a Surveillance Epidemiology and End Results Study. Neuroepidemiology. 2016;46:14–23. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
